Effect of Ginkor Fort on hypoxia-induced neutrophil adherence to human saphenous vein endothelium

Thierry Arnould, Carine Michiels, Dominique Janssens, Nancy Berna, José Remacle

Research output: Contribution to journalArticlepeer-review


This study was performed to evaluate the effects of Ginkor Fort, a renotropic drug composed of Ginkgo biloba extract, troxerutine, and heptaminol, on neutrophil adherence to the endothelium of saphenous veins. When saphenous veins were incubated 2 h in hypoxic conditions, they showed a five- to sixfold increase in neutrophil adherence to the endothelium. Ginkor Fort at 0.3 mg/ml was able to inhibit this increase by 69%. These results were confirmed by observations in scanning electron microscopy. Ginkor Fort also inhibited the subsequent activation of these neutrophils, as evidenced by the inhibition of superoxide anion release. The biochemical mechanism of this inhibition of neutrophil adherence was studied on endothelial cells in culture. We observed that Ginkor Fort was able to inhibit the different steps of the activation of endothelial cells by hypoxia: the activation of phospholipase A2 and the decrease in adenosine triphosphate (ATP) content. By preventing the first step of the activation cascade, the decrease in ATP content, Ginkor Fort blocks the subsequent increase in neutrophil adherence as well as neutrophil activation. The biochemical mechanism evidenced in this work might explain the beneficial effect of this drug in the treatment of patients with chronic venous insufficiency.

Original languageEnglish
Pages (from-to)456-463
Number of pages8
JournalJournal of cardiovascular pharmacology
Issue number3
Publication statusPublished - Mar 1998


  • Chronic venous insufficiency
  • Endothelium
  • Ginkgo biloba extract
  • Human saphenous vein
  • Hypoxia
  • Neutrophils
  • Varicose veins


Dive into the research topics of 'Effect of Ginkor Fort on hypoxia-induced neutrophil adherence to human saphenous vein endothelium'. Together they form a unique fingerprint.

Cite this